Literature DB >> 14575915

A genome-wide screen for linkage disequilibrium in Australian HLA-DRB1*1501 positive multiple sclerosis patients.

M Ban1, S J Sawcer, R N S Heard, B H Bennetts, S Adams, D Booth, V Perich, E Setakis, A Compston, G J Stewart.   

Abstract

The association of multiple sclerosis with alleles/haplotypes from the HLA region on chromosome 6p21 is well established although the remainder of the genome remains relatively unexplored. We have completed a genome-wide screen for linkage disequilibrium in a cohort of Australian multiple sclerosis patients positive for HLA-DRB1*1501. A total of 4346 microsatellite markers provided through the "Genetic Analysis of Multiple sclerosis in EuropeanS" (GAMES) collaborative were analysed in DNA separately pooled from cases (n=217) and controls (n=187). Associations were found in four genomic regions (12q15, 16p13, 18p11 and 19q13) previously identified in linkage genome screens. Three additional regions of novel association were also identified (11q12, 11q23 and 14q21). Further analysis of these regions is required to establish whether the associations observed are due to epistatic interaction with the HLA locus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14575915     DOI: 10.1016/j.jneuroim.2003.08.012

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

1.  Gene expression and genotyping studies implicate the interleukin 7 receptor in the pathogenesis of primary progressive multiple sclerosis.

Authors:  D R Booth; A T Arthur; S M Teutsch; C Bye; J Rubio; P J Armati; J D Pollard; R N S Heard; G J Stewart
Journal:  J Mol Med (Berl)       Date:  2005-08-02       Impact factor: 4.599

2.  A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility.

Authors:  Alessandro Bonetti; Keijo Koivisto; Tuula Pirttilä; Irina Elovaara; Mauri Reunanen; Mikko Laaksonen; Juhani Ruutiainen; Leena Peltonen; Terhi Rantamäki; Pentti J Tienari
Journal:  J Neuroimmunol       Date:  2009-02-04       Impact factor: 3.478

3.  An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians.

Authors:  Matthew J Bugeja; David Booth; Bruce Bennetts; Robert Heard; Justin Rubio; Graeme Stewart
Journal:  BMC Med Genet       Date:  2006-07-26       Impact factor: 2.103

4.  Genes implicated in multiple sclerosis pathogenesis from consilience of genotyping and expression profiles in relapse and remission.

Authors:  Ariel T Arthur; Patricia J Armati; Chris Bye; Robert N S Heard; Graeme J Stewart; John D Pollard; David R Booth
Journal:  BMC Med Genet       Date:  2008-03-19       Impact factor: 2.103

5.  Tumor necrosis factor-alpha polymorphism and susceptibility to multiple sclerosis in the Iranian population.

Authors:  Masoomeh Rahmanian; Mohammad Kargar
Journal:  Iran Red Crescent Med J       Date:  2014-12-27       Impact factor: 0.611

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.